Investor Presentaiton
($ in millions)
CURALEAF NON-IFRS FINANCIAL MEASURES
Managed Revenue
Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Q4 2019
Total Revenue
$
21.4 $ 32.0 $
35.3 $
48.5 $
61.8 $
Revenue from Managed Entities, net of MSA Fees
3.0
2.9
5.4
6.6
11.4
6.2
Q1 2020
75.5 $ 96.5 $
8.5
FY 2017
FY 2018
FY 2019
19.3 $
77.1
$ 221.0
9.0
10.7
29.6
Managed Revenue
$
24.3 $ 34.9
$
40.7 $
55.1 $
73.2 $
81.7 $ 105.0
$
28.4
$
87.8 $ 250.6
Gross Profit on Cannabis Sales
Retail and Wholesale Revenue
$
Costs of Goods Sold
Q3 2018 Q4 2018
16.6 $
7.5
27.8 $
Q1 2019 Q2 2019 Q3 2019 Q4 2019
23.7 $
37.7 $ 50.7 $
12.0
17.1
22.5
27.1
Q1 2020
57.7 $ 77.1
35.7
44.0
FY 2017
FY 2018 FY 2019
$
9.4
$
57.5 $173.9
7.8
31.2
102.4
Gross Profit on Cannabis Sales
$ 9.1
$
11.8 $
10.6 $
15.3 $
23.6 $ 22.0 $
33.0 $
1.5 $ 26.4 $ 71.5
AEBITDA
Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 FY 2017 FY 2018 FY 2019
Net Loss
Interest Expense, Net
Income Tax Recovery (Expense)
Deprecation and Amortization
Share-Based Compensation
$ (35.6) $ (16.5) $ (10.8) $ (24.4) $ (7.4) $ (27.2) $ (15.5) $
(5.0) $ (61.9) $ (69.9)
1.0
2.7
2.6
2.9
4.2
5.1
9.8
(1.4)
2.5
14.8
2.7
1.9
(1.4)
8.2
5.3
12.0
13.2
1.1
5.6
24.1
1.3
3.8
4.9
7.2
10.4
12.7
14.9
3.2
8.7
37.2
(0.0)
1.1
1.8
4.5
4.7
5.7
4.5
2.5
2.2
16.6
Other (Income) Expense
25.1
(0.0)
0.0
1.1
(0.6)
2.8
(2.6)
(1.2)
25.1
3.3
Change in Fair Value of Biological Assets
0.2
1.4
(2.2)
(1.4)
(13.8)
(5.5)
(15.6)
4.1
(0.4) (23.0)
One Time Charges
2.6
4.2
1.5
5.3
7.8
8.3
11.2
0.4
7.8
22.8
AEBITDA
$
(2.8) $
(1.4) $
(3.7) $
3.4 $
10.4 $
13.8 $ 20.0 $
3.8 $ (10.4) $
25.9
curáleaf
40View entire presentation